Long-Term Stability and Age-Dependence of Six Regulatory Serum Proteins

References

• Sargsyan K , MacheinerT, StoryPet al. Sustainability in biobanking: model of Biobank Graz. Biopreserv. Biobank.13(6), 410–420 (2015).
   PubMed Web of Science ®Google Scholar
• Gan R , WangH, SongY, FanJ, XiongY. Chinese biobanking initiatives. Biopreserv. Biobank.13(1), 4–7 (2015).
   PubMed Web of Science ®Google Scholar
• Coppola L , CianfloneA, GrimaldiAMet al. Biobanking in health care: evolution and future directions. J. Transl. Med.17(1), 172 (2019).
   PubMedGoogle Scholar
• Jansen EHJM , BeekhofPK, ViezelieneD, MuzakovaV, SkalickyJ. Long-term stability of oxidative stress biomarkers in human serum. Free Radic. Res.51(11–12), 970–977 (2017).
   PubMed Web of Science ®Google Scholar
• Doumatey AP , ZhouJ, AdeyemoA, RotimiC. High sensitivity C-reactive protein (Hs-CRP) remains highly stable in long-term archived human serum. Clin. Biochem.47(4–5), 315–318 (2014).
   PubMed Web of Science ®Google Scholar
• Hubel A , SpindlerR, SkubitzAPN. Storage of human biospecimens: selection of the optimal storage temperature. Biopreserv. Biobank.12(3), 165–175 (2014).
   PubMed Web of Science ®Google Scholar
• Jack CR Jr , BennettDA, BlennowKet al. NIA-AA Research Framework: toward a biological definition of Alzheimer’s disease. Alzheimers Dement.14(4), 535–562 (2018).
   PubMed Web of Science ®Google Scholar
• Blennow K , ZetterbergH. Biomarkers for Alzheimer’s disease: current status and prospects for the future. J. Intern. Med.284(6), 643–663 (2018).
   PubMed Web of Science ®Google Scholar
• Scheltens P , BlennowK, BretelerMMBet al. Alzheimer’s disease. Lancet388(10043), 505–517 (2016).
   PubMed Web of Science ®Google Scholar
• Jessen F , SpottkeA, BoeckerHet al. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer’s disease (DELCODE). Alzheimers Res. Ther.10(1), 15 (2018).
   PubMedGoogle Scholar
• Trojanowski JQ , VandeersticheleH, KoreckaMet al. Update on the biomarker core of the Alzheimer’s Disease Neuroimaging Initiative subjects. Alzheimers Dement.6(3), 230–238 (2010).
   PubMed Web of Science ®Google Scholar
• Ellis KA , BushAI, DarbyDet al. The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer’s disease. Int. Psychogeriatr.21(4), 672–687 (2009).
   PubMed Web of Science ®Google Scholar
• Vos SJB , VisserPJ, VerheyFet al. Variability of CSF Alzheimer’s disease biomarkers: implications for clinical practice. PLoS ONE9(6), e100784 (2014).
   PubMed Web of Science ®Google Scholar
• Willemse EAJ , van UffelenKWJ, vander Flier WM, TeunissenCE. Effect of long-term storage in biobanks on cerebrospinal fluid biomarker Aβ1–42, T-tau, and P-tau values. Alzheimers Dement.8, 45–50 (2017).
   Google Scholar
• Schipke CG , JessenF, TeipelSet al. Long-term stability of Alzheimer’s disease biomarker proteins in cerebrospinal fluid. J. Alzheimers Dis26(2), 255–262 (2011).
   PubMed Web of Science ®Google Scholar
• Kiddle SJ , VoyleN, DobsonRJB. A blood test for Alzheimer’s disease: progress, challenges, and recommendations. J. Alzheimers Dis.64(Suppl. 1), S289–S297 (2018).
   PubMedGoogle Scholar
• Heneka MT , O’BanionMK. Inflammatory processes in Alzheimer’s disease. J. Neuroimmunol.184(1–2), 69–91 (2007).
   PubMed Web of Science ®Google Scholar
• Schipke CG , GünterO, WeinertCet al. Definition and quantification of six immune- and neuroregulatory serum proteins in healthy and demented elderly. Neurodegener. Dis. Manag.9(4), 193–203 (2019).
   PubMed Web of Science ®Google Scholar
• Schipke CG , MenneF, RubowS, SigleJP, PetersO, GrimmerT. Value of a panel of 6 serum biomarkers to differentiate between healthy controls and mild cognitive impairment due to Alzheimer disease. Alzheimer Dis. Assoc. Disord.34(4), 318–324 (2020).
   PubMed Web of Science ®Google Scholar
• Sjögren M , VandersticheleH, ÅgrenHet al. Tau and Aβ42 in cerebrospinal fluid from healthy adults 21–93 years of age: establishment of reference values. Clin. Chem.47(10), 1776–1781 (2001).
   PubMed Web of Science ®Google Scholar
• Pinchuk I , WeberD, KochlikBet al. Gender- and age-dependencies of oxidative stress, as detected based on the steady state concentrations of different biomarkers in the MARK-AGE study. Redox Biol.24, 101204 (2019).
   PubMed Web of Science ®Google Scholar
• Portela LVC , TortABL, SchafDVet al. The serum S100B concentration is age dependent. Clin. Chem.48(6), 950–952 (2002).
   PubMed Web of Science ®Google Scholar
• Piriz J , MullerA, TrejoJL, Torres-AlemanI. IGF-I and the aging mammalian brain. Exp. Gerontol.46(2–3), 96–99 (2011).
   PubMed Web of Science ®Google Scholar
• Mateo I , LlorcaJ, InfanteJet al. Low serum VEGF levels are associated with Alzheimer’s disease. Acta Neurol. Scand.116(1), 56–58 (2007).
   PubMed Web of Science ®Google Scholar
• Motta M , ImbesiR, DiRosa M, StivalaF, MalaguarneraL. Altered plasma cytokine levels in Alzheimer’s disease: correlation with the disease progression. Immunol. Lett.114(1), 46–51 (2007).
   PubMed Web of Science ®Google Scholar
• Galimberti D , FenoglioC, LovatiCet al. Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer’s disease. Neurobiol. Aging27(12), 1763–1768 (2006).
   PubMed Web of Science ®Google Scholar
• Mathys J , GholamrezaeeM, HenryH, von GuntenA, PoppJ. Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer’s pathology in MCI and mild dementia. Exp. Gerontol.100, 45–53 (2017).
   PubMed Web of Science ®Google Scholar
• Bowman GL , DayonL, KirklandRet al. Blood–brain barrier breakdown, neuroinflammation, and cognitive decline in older adults. Alzheimers Dement.14(12), 1640–1650 (2018).
   PubMed Web of Science ®Google Scholar
• Popp J , OikonomidiA, TautvydaitėDet al. Markers of neuroinflammation associated with Alzheimer’s disease pathology in older adults. Brain Behav. Immun.62, 203–211 (2017).
   PubMed Web of Science ®Google Scholar
• O’Bryant SE , ListaS, RissmanRAet al. Comparing biological markers of Alzheimer’s disease across blood fraction and platforms: comparing apples to oranges. Alzheimers Dement.3, 27–34 (2016).
   Google Scholar
• Polyakova M , SchlöglH, SacherJet al. Stability of BDNF in human samples stored up to 6 months and correlations of serum and EDTA-plasma concentrations. Int. J. Mol. Sci.18(6), 1189 (2017).
   PubMed Web of Science ®Google Scholar
• Ito Y , NakachiK, ImaiKet al. Stability of frozen serum levels of insulin-like growth factor-I, insulin-like growth factor-II, insulin-like growth factor binding protein-3, transforming growth factor β, soluble Fas, and superoxide dismutase activity for the JACC Study. J. Epidemiol.15(Suppl. 1), S67–S73 (2005).
   PubMedGoogle Scholar
• Muller YA , ChristingerHW, KeytBA, DeVos AM. The crystal structure of vascular endothelial growth factor (VEGF) refined to 1.93 Å resolution: multiple copy flexibility and receptor binding. Structure5(10), 1325–1338 (1997).
   PubMed Web of Science ®Google Scholar
• Hinck AP . Structural studies of the TGF-βs and their receptors – insights into evolution of the TGF-β superfamily. FEBS Lett.586(14), 1860–1870 (2012).
   PubMed Web of Science ®Google Scholar
• Narhi LO , RosenfeldR, TalvenheimoJet al. Comparison of the biophysical characteristics of human brain-derived neurotrophic factor, neurotrophin-3, and nerve growth factor. J. Biol. Chem.268(18), 13309–13317 (1993).
   PubMed Web of Science ®Google Scholar